# PHYRAGO
> **NDA216099** · New Drug Application · Sponsor: HANDA THERAP · Approved 2023-12-05
## Drug
- **FDA Application Number:** NDA216099
- **Application type:** New Drug Application
- **Brand name:** PHYRAGO
- **Generic name:** DASATINIB
- **Active ingredients:** DASATINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HANDA THERAP
- **Manufacturer:** Cycle Pharmaceuticals Ltd
- **First approval:** 2023-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216099)
---
*AI Analytics · CC0 1.0*